Abbott India Limited
Nippon India Mutual Fund increased its stake in the company from 1.07% to 1.32%, purchasing 52,135 shares.
A leading multinational pharmaceutical company operating in India since 1944, Abbott India manufactures and distributes a comprehensive portfolio of medicines, nutritional products, and diagnostic solutions across the country. The company serves the Indian market through an extensive network of independent distributors, focusing on therapeutic areas including cardiovascular health, gastroenterology, and nutrition. Its integrated operations span research, development, and commercialization of pharmaceutical products tailored to meet diverse Indian healthcare needs and patient requirements.
India's fifth-largest AMC with over Rs 6 lakh crore in AUM, backed by Japan's Nippon Life Insurance which holds majority stake. Formerly Reliance MF, rebranded in 2019 after Nippon's acquisition. Sailesh Raj Bhan has run the equity book for over two decades and is one of India's most experienced active managers. Known for sector rotational calls and a deep research bench.